Week of April 15, 2019
Stocks advanced on Friday as exports in China rocketed 14.2% year over year. That was far greater than forecasts for just 8.7%, and follows a sharp drop in February 2019. Markets exploded even higher after JPMorgan Chase and Wells Fargo both beat earnings forecasts.
JPMorgan’s first quarter profits were up 5% to $9.18 billion, or $2.65 a share, as compared to estimates for $2.35. Revenue was up 5% to $29.9 billion, exceeding estimates by $1.5 billion.
“We had record revenue and net income, strong performance across each of our major businesses and more constructive environment,” said CEO Jamie Dimon, as quoted by CNBC. “Even amid some global geopolitical uncertainty, the U.S. economy continues to grow, employment and wages are going up, inflation is moderate, financial markets are healthy and consumer and business confidence remains strong.”
Wells Fargo also posted better than expected quarterly earnings of $1.20 a share, as compared to expectations for $1.09. Revenue came in at $21.609 billion, as compared to $21.012 billion estimates. Also, in the quarter, the company returned $6 billion to shareholders through dividend payments and stock buybacks.
“Our financial results included continued strong credit performance and high levels of liquidity,” CFO John Shrewsberry said, as quoted by CNBC. “In addition, our continued de-risking of the balance sheet and consistent level of profitability have resulted in capital levels well above our regulatory minimum.”
In short, there’s plenty to be excited about on Wall Street these days.
Opportunity No. 1
Etsy Inc. (ETSY)
Etsy operates as a commerce platform to make, sell, and buy goods online and offline worldwide. Its platform includes its markets, services, and technology, which enabled users to engage its community of sellers and buyers. After hitting a new high of $70, the stock has pulled back slightly to oversold conditions. With improving fundamentals, we strongly believe ETSY could be an $80 stock, near-term.
Opportunity No. 2
Heron Therapeutics (HRTX)
As it nears the FDA’s April 30, 2019 decision on HTX-011 for the management of postoperative pain, the stock is just beginning to push higher. In studies, patients on HTX-011 saw less pain intensity than those given bupivacaine.
Opportunity No. 3
Snap Inc. (SNAP)
Unbelievably, SNAP is one of the strongest stocks of the year so far. In fact, it’s already run from $5.50 to $11.65. As analysts become much more bullish, we’re jumping into to the excitement, too. That’s because of recent SNAP launches, including Snap Games, Snap Scan (an augmented reality platform), and the fact the company has stopped losing as many daily active users. Even its average revenue per user is just beginning to increase. Company revenue hit a record $390 million, up 36% year over year.
Listed below are some of the stocks opportunities we’ve mentioned, date of mention, the closing price on that day and the current price.
- Editas Medicine (EDIT) – 3/15/19 – $24.29 to $26
- Momo Inc. (MOMO) – 3/15/19 – $38.50 to $38.08
- Nektar Therapeutics (NKTR) – 3/15/19 – $35.53 to $36.30
- Aerojet Rocketdyne Holdings (AJRD) – 3/22/19 – $33.50 to $33.52
- Marathon Oil Corporation (MRO) – 3/22/19 – $16.68 to $17.19
- Boingo Wireless Inc. (WIFI) – 3/22/19 — $22.02 to $25.26
- H&E Equipment Services (HEES) – 3/29/19 — $25.11 to $27.63
- Coca-Cola (KO) – 3/29/19 – $46.86 to $46.41
- Nike Inc. (NKE) – 3/29/19 – $84.21 to $85.40
- Nabriva Therapeutics (NBRV) – 3/5/19 – $2.80 to $2.80
- Advanced Micro Devices (AMD) – 3/5/19 – $28.98 to $27.44
- Bank of America (BAC) – 3/5/19 – $29.08 to $29.25